Clinical Challenges

Carcinoid Tumor

Joyce Chowsanitphon

carcinoid
ONF 2010, 37(6), 677-679. DOI: 10.1188/10.ONF.677-679

Jump to a section

    References

    American Cancer Society. (2010). Gastrointestinal carcinoid tumors: What are the key statistics about gastrointestinal carcinoid tumors? Retrieved from http://www.cancer.org/Cancer/GastrointestinalCarcinoidTumor/DetailedGuide/gastrointestinal-carcinoid-tumors-key-statistics
    Benson, A. B., Myerson, R. J., & Hoffman, J. (2007). Pancreatic, neuroendocrine GI, and adrenal cancers. In R. Pazdur, L. R. Coia, W. J. Hoskins, & L. D. Wagnman (Eds.), Cancer management: A multidisciplinary approach (10th ed., pp. 287-310). Lawrence, KS: CMP Medica.
    Kulke, M. H., Lenz, H., Meropol, N. J., Posey, J., Ryan, D. P., Picus, J…. Fuchs, C. S. (2008). Activity of sunitinib in patients with advanced neuroendocrine tumors. Journal of Clinical Oncology, 26, 3403-3410. dx.doi.org/10.1200/JCO.2007.15.9020
    National Comprehensive Cancer Network. (2010). NCCN Clinical Practice Guidelines in Oncology™: Neuroendocrine tumors. Retrieved from http://www.nccn.org/professionals/physician_gls/PDF/neuroendocrine.pdf
    Parra, I., Remacha, A., Costilla, S., & Caleron, J. A. (2002). Thymic carcinoid tumors. Canadian Respiratory Journal, 9, 215-216.
    Pinchot, S. N., Holen, K., Sippel, R. S., & Chen, H. (2008). Carcinoid tumors. Oncologist, 13, 1255-1269. dx.doi.org/10.1634/theoncologist.2008-0207
    Rinke, A., Muller, H., Schade-Brittinger, C., Klose, K., Barth, P., Wied, M…. Arnold, R. (2009). Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: A report from the PROMID study group. Journal of Clinical Oncology, 27, 4656-4663. dx.doi.org/10.1200/JCO.2009.22.8510
    Yao, J. C., Phan, A. T., Chang, D. Z., Wolff, R. A., Hess, K., Gupta, S…. Meric-Bernstam, F. (2008). Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low-to- intermediate-grade neuroendocrine tumors: Results of a phase II study. Journal of Clinical Oncology, 26, 4311-4318.
    Yao, J.C, Phan, A. T., Hoff, P. M., Chen, H. X., Charnsangavej, C., Yeung, S. J…. Ajani, J. A. (2008). Targeting vascular endothelial growth factor in advanced carcinoid tumor: A random assignment phase II study of depot octreotide. Journal of Clinical Oncology, 26, 1316-1323. dx.doi.org/10.1200/JCO.2007.13.6374
    Zuetenhorst, J. M., & Taal, B. G. (2005). Metastatic carcinoid tumors: A clinical review. Oncologist, 10, 123-131.